Vimarsana
Biggest News Aggregation in the World

Page 10 - Roxana Mehran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roxana Mehran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roxana Mehran Today - Breaking & Trending Today

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award - Vimarsana News

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young Investigator Award is Jennifer Rymer, MD, MBA, MHS, John Bush Simpson Assistant Professor of Medicine at the Duke University Medical Center, Durham, NC.

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI - Vimarsana News

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Starting alirocumab in the hospital dropped lipids to levels not seen in sham-treated patients, paving the way for larger trials.

Source: tctmd.com
RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion - Vimarsana News

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

The idea of preserving the radial artery for future needs, including CABG and hemodialysis, is important, Roxana Mehran says.

Source: tctmd.com
Legacy of Neutral SYMPLICITY HTN-3 Recast by Long-term Outcomes - Vimarsana News

Legacy of Neutral SYMPLICITY HTN-3 Recast by Long-term Outcomes

Although interest in renal denervation in hypertension fell off after disappointing results from the 2014 trial, a new, longer-term analysis argues the treatment may have 'worked' after all.

Brief Anticoagulation Preserves Radial Artery After Catheter Access - Vimarsana News

Brief Anticoagulation Preserves Radial Artery After Catheter Access

Trial shows promise of a short course of direct-acting oral anticoagulant